Capex / revenue moved 232 bp higher
Capex / revenue changed +232 basis points from the comparable as-filed period.
1.41%→3.73%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PLCE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure increased 135.4%
Capital expenditure changed +135.4% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
$3.4M→$8.0M5 prior comparisons
Free-cash-flow proxy decreased 33.3%
Free-cash-flow proxy changed -33.3% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
-$46.4M→-$61.8M5 prior comparisons
Gross margin moved 445 bp lower
Gross margin changed -445 basis points from the comparable as-filed period.
29.23%→24.79%3 prior comparisons
Gross profit decreased 24.6%
Gross profit changed -24.6% from the comparable as-filed period.
$70.8M→$53.4M3 prior comparisons
Inventory decreased 22.7%
Inventory changed -22.7% from the comparable as-filed period.
$422.2M→$326.4M3 prior comparisons
Net income decreased 56.3%
Net income changed -56.3% from the comparable as-filed period.
-$34.0M→-$53.2M3 prior comparisons
Operating cash flow decreased 25.2%
Operating cash flow changed -25.2% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
-$43.0M→-$53.8M6 prior comparisons
Operating income decreased 74.9%
Operating income changed -74.9% from the comparable as-filed period.
-$24.1M→-$42.2M3 prior comparisons
Operating margin moved 964 bp lower
Operating margin changed -964 basis points from the comparable as-filed period.
-9.96%→-19.60%3 prior comparisons
Stock-based compensation decreased 124.3%
Stock-based compensation changed -124.3% from the comparable as-filed period.
$1.7M→-$425,0003 prior comparisons
Cash & equivalents decreased 16.0%
Cash & equivalents changed -16.0% from the comparable as-filed period.
$5.7M→$4.8M2 prior comparisons
Revenue decreased 11.1%
Revenue changed -11.1% from the comparable as-filed period.
$242.1M→$215.2M3 prior comparisons
Selling, general & administrative increased 2.5%
Selling, general & administrative changed +2.5% from the comparable as-filed period.
$86.7M→$88.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.